AOD 9604 (an abbreviation for Anti-Obesity Drug 9604) was first developed in the 1990s in Australia in the laboratory of Professor Frank Ng, a biochemist with a long research focus on growth hormone biology
Format: Multi-dose vial
Take the extra 30 seconds to tap bubbles out and verify your volume before injecting into the semaglutide vial
Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias
Note: Avoid mixing with high-concentration Vitamin C (L-ascorbic acid) or strong acids in the same step, as they may destabilize the copper ions